PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

PHASE1RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 19, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 1, 2030

Conditions
Solid TumorAdult
Interventions
BIOLOGICAL

PIN +anti-PD1

"1. Initial treatment phase:~ PIN injection frequency: day0 and day 3, per 3 weeks for 8 cycles;~ PIN injection dosage:~ Cycle1: 4e9 or 8e9 viral particles of PIN based on the number of injectable lesions, their longest diameter, and the tumor volume capacity .~ Cycle 2\~8: 4e9 or 8e9 viral particles of PIN based on the tumor volume's capacity.~ Anti-PD1: day -3, per 3 weeks for 8 cycles;~2. Maintenance treatment phase:~ No injection lesion: Anti-PD1: day 1, per 3 weeks till 2 years unless PD or serious intolerable AEs.~ Have injection lesion:~ PIN: 4e9 or 8e9 viral particles based on the tumor volume's capacity, per 6 weeks (within first 24 weeks), then per 8 weeks till 2 years unless unavailability of injection lesion, PD or serious intolerable AEs.~ Anti-PD1: day 1, per 3 weeks till 2 years unless PD or serious intolerable AEs.~3. Salvage treatment phase:~Dosage and frequency of administration refer to the initial treatment phase and maintenance treatment phase."

Trial Locations (1)

Unknown

RECRUITING

Biotherapeutic Department of Chinsese PLA Gereral Hospital, Beijing

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Changping Laboratory

OTHER

lead

Chinese PLA General Hospital

OTHER

NCT06883149 - PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor | Biotech Hunter | Biotech Hunter